What is HPT Pharma?
With over 25 years of operational experience, HPT Pharma has carved a niche in delivering innovative, timely, and cost-effective blister packaging solutions. The company's expertise spans precision blister tooling design and manufacturing, catering to a diverse clientele that includes pharmaceutical manufacturers, contract packaging organizations, and clinical trial packaging providers. HPT Pharma is distinguished by its rapid lead times and robust in-house CNC machining capabilities, ensuring high-quality support for critical blister packaging requirements within the life sciences industry.
How much funding has HPT Pharma raised?
HPT Pharma has raised a total of $932K across 2 funding rounds:
Debt
$350K
Debt
$582K
Debt (2020): $350K with participation from PPP
Debt (2021): $582K led by PPP
Key Investors in HPT Pharma
PPP
Public-Private Partnership
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed investor participated in the recent funding round, contributing to the major strategic investment in HPT Pharma.
What's next for HPT Pharma?
The recent major strategic investment signals a pivotal growth phase for HPT Pharma. This capital infusion is expected to fuel further advancements in their specialized tooling and engineering solutions, potentially expanding their market reach and enhancing their technological capabilities. The company's focus on faster lead times and precision manufacturing positions it to capitalize on the increasing demand for efficient and reliable packaging within the pharmaceutical and nutraceutical industries, suggesting a trajectory towards scaling operations and solidifying its competitive advantage.
See full HPT Pharma company page
